Literature DB >> 7455996

Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis.

T H Tran, H Bounameaux, C Bondeli, H Honkanen, G A Marbet, F Duckert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7455996

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  6 in total

Review 1.  Familial venous thrombosis.

Authors:  J H Winter; A S Douglas
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

2.  Isolation and sequence characterization of a cDNA clone of human antithrombin III.

Authors:  T Chandra; R Stackhouse; V J Kidd; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

3.  Genetic mapping of the structural gene for antithrombin III to human chromosome 1.

Authors:  F T Kao; H G Morse; M L Law; A Lidsky; T Chandra; S L Woo
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Authors:  A Girolami; F Fabris; G Cappellato; L Sainati; G Boeri
Journal:  Blut       Date:  1983-08

5.  Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Authors:  T Koide; S Odani; K Takahashi; T Ono; N Sakuragawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.

Authors:  D Stern; P Nawroth; J Marcum; D Handley; W Kisiel; R Rosenberg; K Stern
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.